CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.240
https://www.valueinhealthjournal.com/article/S1098-3015(24)00355-3/fulltext
Title :
CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00355-3&doi=10.1016/j.jval.2024.03.240
First page :
Section Title :
Open access? :
No
Section Order :
11597